Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-04 Sale | 2021-01-06 5:02 pm | ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil President and CEO | 105,693 | $2.71 | $286,428 | 1,799,280 (Direct) | View |
| 2019-12-30 Sale | 2019-12-31 4:37 pm | ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil Chief Executive Officer | 110,694 | $4.88 | $540,187 | 2,220,444 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-29 Option Award | 2020-01-31 4:45 pm | N/A 2030-01-29 | ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil Chief Executive Officer | 435,900 | $0 | 2,169,173 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 4:37 pm | N/A 2029-01-06 | ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil Chief Executive Officer | 44,642 | $0 | 2,220,444 (Direct) | View |
| 2019-12-27 Exercise | 2019-12-31 4:37 pm | N/A N/A | ZIOPHARM ONCOLOGY INC | ZIOP | Cooper Laurence James Neil Chief Executive Officer | 44,642 | $2.24 | 2,220,444 (Direct) | View |